European Patients' Academy on Therapeutic Innovation

The European Patients’ Academy on Therapeutic Innovation (EUPATI) is a multi-stakeholder public-private partnership established as an independent non-profit Foundation in the Netherlands.

EUPATI provides education and training to increase the capacity and capability of patients and patient representatives to understand and meaningfully contribute to medicines research and development (R&D), and to improve the availability of medical information for patients and other stakeholders.

Who are we?

What is our goal?

The objective of EUPATI is to provide appropriate academic and rigorous training, yet presented in a way that enables concrete and applicable learning outcomes for the patient community, leading to measurable impact in medicines development.

EUPATI Open Classroom learning strategies in a digital environment

 

Who creates our content?

EUPATI stands for quality, ensuring transparency, accessibility and factual accuracy. All educational content is developed with a consistent multi-stakeholder approach. The expertise and insights from al EUPATI partners, network members and external advisors are supported by qualitative and quantitative research as well as a systematic literature review conducted by EUPATI prior to content production. EUPATI has also established an independent Editorial Board.

Please, find a list of individuals who have contributed to the development and revision of the EUPATI Open Classroom online courses.

Who was involved in the development of the EUPATI Open Classroom?

 

EUPATI Open Classroom  was supported by the EUPATI Reload project, funded by EIT Health (EIT Health is supported by EIT, a body of the European Union) and made possible together great partners – Bayer, University of Copenhagen, University of Oxford and Medtronic.

 

 

Partners